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Abstract
Background: Appropriate use of antibiotic in children with urinary tract infection (UTI) is essential so as to curb the spread of drug-resistant 
organisms. Objectives: To study the bacteriological profile and antibiotic sensitivity pattern in children with UTI and to determine the 
prevalence of extended-spectrum β-lactamase (ESBL) producers of Escherichia coli and Klebsiella species. Methods: This prospective 
study was conducted from October 2010 to September 2011. The children between age group of 3 and 14 years who attended Pediatric 
Department at a tertiary care hospital were included in the study. Single midstream urine specimen was collected from each patient with 
suspected UTI. Result: Out of 184 urine samples with suspected UTI, 122 children had culture-proven UTI. Of 122 cases, 81 (66.39%) 
cases were seen in females. The most common organism isolated was E. coli (50%) followed by Klebsiella pneumoniae (23.77%) and 
Enterococcus species (8.19%). E. coli, Klebsiella spp., Citrobacter freundii, and Proteus mirabilis responded better to nitrofurantoin (NIT) 
(76.8%). Ceftriaxone (79.12%), cefotaxime (74.8%), and cefixime (71.7%) showed higher sensitivity as compared to ceftazidime (63.4%) 
and cefoperazone (CPZ) (59.4%). Among aminoglycosides, amikacin (82.4%) had a better response as compared to gentamicin (64.6%). Out 
of 61 E. coli and 31 Klebsiella species, 35 (38.04%) were ESBL producers. The sensitivity of these organisms to imipenem was 100% with a 
good response to meropenem, CPZ-sulbactam, and piperacillin-tazobactam. Conclusion: E. coli and Klebsiella spp. were the most common 
isolates and many of them were ESBL producers. NIT seemed to be a reasonable alternative to cephalosporins for the treatment of UTIs in 
children. Carbapenems were found to be effective in ESBLs and non-ESBL producing uropathogens and can be considered as reserve drugs.
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Urinary tract infection (UTI) is the third most leading cause of infection in pediatric patients causing high morbidity and mortality [1]. Since it presents with 
non-specific symptoms in young children, it sometimes 
goes undiagnosed. It results into complications such as renal 
scarring, hypertension, and chronic renal failure [2]. Thus, 
improperly treated UTI in children is a cause for both clinical 
and public concern.
Diagnostic approach to UTI is based on both clinical and 
laboratory evaluation. Practically microscopic analysis alone 
is enough for diagnosis of UTI along with clinical correlation. 
However, sensitivity, specificity, and predictive values of this 
test vary according to the patient population studied. Thus, 
urine culture still remains a gold standard.
The prevalence of extended-spectrum β-lactamase (ESBL) 
among clinical isolates varies from country to country and 
from institution to institution. Over the last few decades, 
there were outbreaks of ESBLs has been observed worldwide, 
which pose a great threat to commonly used cephalosporin [2]. 
In the United States, the occurrence of ESBL production in 
Enterobacteriaceae ranges from 0 to 25%, depending on the 
institution, with the national average being around 3% [3]. 
Its prevalence is around 21.7% in Europe [4]. Elsewhere in 
Asia, the percentage of ESBL production in Escherichia coli 
and Klebsiella pneumoniae varies from 4.8% in Korea to 
8.5% in Taiwan and up to 12% in Hong Kong [5]. In India, the 
prevalence of ESBL phenotypes in E. coli, K. pneumoniae, and 
Salmonella species is >61%, >55%, and 3-8%, respectively [6]. 
It is interesting that specific ESBLs appear to be unique to a 
certain country or region. For example, TEM-10 has been 
responsible for several unrelated outbreaks of ESBL-producing 
organisms in the United States [3].
Hence, there is a need to have an early diagnosis of UTI 
to reduce morbidity, mortality and also need to emphasize 
on appropriate antibiotic selection so as to curb the spread of 
Shettigar et al. Bacterial profile of UTI in children
Vol 3 | Issue 1 | Jan - Mar 2016 Indian J Child Health 28
drug-resistant bugs. In view of above concern, this study has 
been taken up.
MATERIALS AND METHODS
This prospective study was conducted from October 2010 
to September 2011 in the Department of Pediatrics and 
Microbiology of a tertiary care teaching hospital. The study 
was carried out after obtaining prior approval from the Ethical 
Committee. An informed consent was taken from patient’s 
caretakers. Children between 3 and 14 years of age who have 
admitted to pediatric ward from October 2010 to September 
2011 with a clinical diagnosis of UTI were included. The 
diagnosis was made in the presence of a history of fever with 
any of the symptoms such as dysuria/excessive cry while 
micturition, increased frequency, burning micturition, or 
suprapubic pain/flank pain. Those children who had undergone 
bladder catheterization or had received antibiotics within 48 h 
prior to attending the hospital and samples which grew more 
than one type of organism was considered as contaminated and 
hence, excluded from this study.
After taking all precautions, a freshly voided clean catch 
midstream urine sample was collected in a commercially 
available sterile and wide-mouthed plastic container meant for 
urinalysis and urine culture. Urine was cultured on cytokine 
lactose electrolyte deficient agar using a 0.001 ml calibrated 
wire loop and incubated at 37°C for 24 h. Urine wet mount 
examination and Gram-stain of an uncentrifuged sample were 
also done and examined for the presence of pus cells and 
organisms.
Next morning, the isolates were identified by colony 
morphology, Gram-stain, motility test, and routine biochemical 
reactions using standard laboratory procedures [7,8]. In cases, 
where Gram-negative bacilli were isolated, colony count of more 
than 105/ml of a single organism was considered diagnostic of 
UTI [9]. Samples which grew more than one type of organism 
(multiple growths) were considered as contaminated and were 
not taken as positive for infection.
Antibiotic sensitivity was put up by the Kirby-Bauer disk 
diffusion method using commercially available antibiotic discs 
(HiMedia) following the Clinical Laboratory Standard Institute 
(CLSI) guidelines [10]. E. coli and Klebsiella spp. were 
screened for ESBL production by disk diffusion method with 
ceftazidime (CAZ) and ceftriaxone disks as recommended by 
CLSI Guidelines. Phenotypic confirmation was done by double 
disk diffusion test and phenotypic confirmatory disk diffusion 
test.
Statistical Analysis
Relationships between variables were analyzed using Chi-
square test, Fisher’s exact test. p<0.05 was considered 
statistically significant. The analysis was done by the SPSS 
version 17.0 statistical software.
RESULTS
During 1-year of the study period, a total number of 184 children 
between age group of 3 years and 14 years with suspected 
UTI were evaluated. Out of these patients, 122 children were 
diagnosed to have UTI. The most common organism isolated 
was E. coli (50%), followed by K. pneumonia (Fig. 1).
About 60% of E. coli were sensitive to third-generation 
cephalosporins. Among aminoglycosides, amikacin (AK) was 
the most sensitive antibiotic (65.57%). K. pneumoniae was 
equally sensitive (65.51%) to nitrofurantoin (NIT) and AK 
followed by gentamicin (GEN) (58.62%) (Table 1).
Acinetobacter baumannii isolates were found to be highly 
sensitive (100%) to meropenem (MRP) and imipenem (IPM). 
It was highly resistant to norfloxacin (100%), ciprofloxacin 
(87.5%), and GEN (87.5%). Pseudomonas aeruginosa isolates 
were sensitive to most of the antibiotics. However, numbers of 
patients were few to give conclusive results (Fig. 2).
Enterococcus species were 100% sensitive to vancomycin, 
linezolid, and teicoplanin. It was most resistant to 
Figure 1: Organisms isolated on culture
Figure 2: Resistance pattern of non-lactose fermenters 
to antibiotics. AT: Aztreonam, CPZ: Cefoperazone, 
MRP: Meropenem, TOB: Tobramycin, IPM: Imipenem, 
CIP: Ciprofloxacin, PI: Piperacillin
Shettigar et al. Bacterial profile of UTI in children
Vol 3 | Issue 1 | Jan - Mar 2016 Indian J Child Health 29
amoxicillin-clavulanic acid (70%), NIT (60%), and high-level 
aminoglycoside-resistant GEN (50%).
Out of 92 E coli and Klebsiella species, 35 (38.04%) 
were ESBL producers. Of these 35 ESBL producers, 23 cases 
(65.71%) were E coli (Table 2).
Sensitivity to IPM was 100% in both E coli and 
Klebsiella spp. and with a good sensitivity pattern to MRP, 
cefoperazone (CPZ)-sulbactam, and piperacillin-tazobactam 
(PIT). However, Klebsiella spp. was most resistant (66.66%) to 
amoxicillin-clavulanic acid (Table 3).
DISCUSSION
In the present study, the most common organism isolated 
from patients with UTI was E coli (50%) followed by 
K. pneumoniae (23.77%) and others. Similarly, Boloor et al. [2]
observed E coli (53%) as the most predominant uropathogen 
followed by P. aeruginosa (9.8%) and K. pneumoniae 
(7.4%). They have isolated Staphylococcus in 4.9% and 
Group B Streptococci in 1.6% cases. Taneja et al. [11] and 
Mashouf et al. [12] have also detected Staphylococcus (1.7%) 
and Coagulase negative Staphylococcus (3.2%), respectively. 
Unlike we have not been able to isolate Staphylococcus spp. 
or any other Gram-positive organisms except for Enterococcus 
faecalis.
From our study, it was observed that E. coli, Klebsiella 
spp., Citrobacter freundii, and Proteus mirabilis responded 
better to NIT (76.8%) and third-generation cephalosporins. 
Among aminoglycosides, AK (82.4%) had the better response 
as compared to GEN (64.6%). Poor response was seen with 
ampicillin (AMP) (35.6%); whereas, co-trimoxazole (COT) 
(56.8%) and norfloxacin (58.9%) had an average response. 
Thus, physicians can still continue to prescribe NIT, cefixime, 
norfloxacin, and COT in outpatients as these drugs are available 
in oral forms. Susceptibility pattern to the above-mentioned 
antibiotics did not show a major variation among ESBL and 
non-ESBL producers.
Further, ESBL producing E. coli and K. pneumoniae has 
shown 100% sensitivity to imipenem and with a good sensitivity 
pattern to MRP, CPZ-sulbactam, and PIT. However, Klebsiella 
spp. was most resistant (66.66%) to amoxicillin-clavulanic 
acid. P. aeruginosa was isolated in only two cases. Hence, it 
was difficult to assess overall sensitivity pattern. In both the 
cases, organisms were sensitive to AK, aztreonam, CPZ, MRP, 
and IPM. One of the isolates was resistant to fluoroquinolones, 
PI, and GEN.
A. baumannii showed the better response to carbapenems 
(100% sensitive). CPZ and CAZ had almost similar sensitivity 
pattern (75%). Aminoglycosides were seen to be quite 
ineffective. E. faecalis isolates were found to be 100% sensitive 
to vancomycin, linezolid, and teicoplanin. Norfloxacin was 
found to be sensitive in about 60% of the cases. Nearly 
40-50% isolates were sensitive to NIT and high-level GEN. 
Almost 70% of the organisms were resistant to amoxicillin-
clavulanic acid.
There is a variation in frequency and sensitivity pattern 
among ESBL producing E. coli and Klebsiella spp. isolates. 
Some studies show a higher percentage of ESBLs producing 
E. coli isolates and others Klebsiella spp. As reported by Allen 
and colleagues, out of 1636 isolates of E. coli from children in 
Canada, 736 (45%) were resistant to AMP, 514 (31.4%) were 
resistant to COT, and 22.2% were resistant to both [13]. In the 
Table 3: Antibiotic sensitivity pattern of ESBL producers
Organisms Sensitivity of ESBL producers 
to antibiotics (%)
AMC CFS PIT MRP IPM
Escherichia coli 52.17 65.21 60.86 95.62 100
Klebsiella spp. 33.33 66.66 58.33 91.66 100
CFS: Cefoperazone-sulbactam, PIT: Piperacillin- 
tazobactam, MRP: Meropenem, IPM: Imipenem
Table 1: Antibiotic sensitivity pattern of Enterobacteriaceae
Organisms Frequency of resistance of isolates to antibiotics (%)
AMP COT GEN AK NA NIT NX CAZ CTR CTX CPZ CFM
Escherichia coli 75.04 72.13 60.65 34.42 62.29 39.34 63.93 42.6 37.7 39.3 40.9 39.34
Klebsiella pneumoniae 79.31 68.96 41.37 34.48 58.62 34.48 58.62 48.3 41.4 44.8 44.8 51.72
Klebsiella oxytoca 50.00 0 0 0 0 0 0 50.0 0 0 50.0 50.00
Citrobacter freundii 66.66 50.00 50.00 16.66 33.33 16.66 33.33 16.6 0 16.6 16.6 0
Proteus mirabilis 50.00 25.00 25.00 0 0 25.00 50.00 25.0 25.0 25.0 50.0 0
AMP: Ampicillin, COT: Co-trimoxazole, GEN: Gentamicin, AK: Amikacin, NIT: Nitrofurantoin, NX: Nalidixic acid, 
CAZ: Ceftazidime, CTR: Ceftriaxone, CTX: Cefotaxime, CPZ: Cefoperazone, CFM: Cefixime
Table 2: Prevalence of ESBL producers of Escherichia coli 
and Klebsiella species
Organisms ESBL (%) Non-ESBL (%)
Escherichia coli (n=61) 23 (37.7) 38 (62.3)
Klebsiella spp. (n=31) 12 (38.7) 19 (61.3)
Total (n=92) 35 57
ESBL: Extended‑spectrum β‑lactamase
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present study, 73.4% isolates of E. coli were resistant to both, 
which is quite high. This, in turn, suggests the limited role of 
inexpensive first line agents in our set up.
Hasan et al. [14] conducted a study in New Delhi and stated 
multi drug resistance (MDR) was most commonly associated 
with Enterococci spp. (77.8%) followed by P. aeruginosa 
(65.1%), E. coli (52.9%), K. pneumoniae (48%), and 
Staphylococcus aureus (38.8%). Drugs which retained their 
effectiveness for Gram-negative bacilli were AK (47.3%), 
norfloxacin (33%), and cefotaxime (CTX) (42%). They have 
also tested susceptibility to lincomycin (86.1%) and netilmicin 
(35.4%) which we could not test in our study. Gram-positive 
cocci showed sensitivity to vancomycin and teicoplanin (100% 
each) and norfloxacin (41%). This was similar to the present 
study.
Shobha et al. [15] in Manipal, Karnataka, reported that 27.39% 
K. pneumoniae isolates and 25.39% E. coli were ESBL producers 
by the phenotypic confirmatory method. All ESBL producers 
were found to be susceptible to AK and IPM, which was in 
concordance with the present study.
Tankhiwala et al. [16] evaluated ESBLs in urinary isolates 
in Nagpur and observed 82% of bacterial uropathogens 
were resistant to COT and 79.2% to AMP. However, some 
isolates were susceptible to NIT (62.5%), CTX (58.7%), 
and norfloxacin (44.9%). AK was found to be the drug of 
choice in P. aeruginosa (85.7%). Nearly, 73.5% of Gram-
negative bacilli were resistant to nalidixic acid. However, 
in the present study, these drugs were found to show better 
susceptibility pattern thus, giving a reasonable option for 
treatment.
In contrast to the present study, Khurana et al. found a higher 
percentage of ESBL producer K. pneumoniae isolates (38.5%) 
as compared to E. coli (24.7%) [17]. Furthermore, there was no 
significant difference between ESBL producers and non-ESBL 
producers in the susceptibility to non-beta lactam agents except 
for GEN.
One limitation of our study was that we could not get 
the Ethical Committee clearance for suprapubic aspiration 
to collect a urine sample. Therefore, we could not include 
children <3 years. Though suprapubic aspiration is ideal, 
midstream urine sampling is more practicable as well as 
possible in children above 3 years of age after proper training 
of caretakers.
CONCLUSION
NIT seemed to be a reasonable alternative to cephalosporins 
for the treatment of UTIs in children. Third-generation 
cephalosporins still showed a good response in non-
ESBLs. AK and carbapenems were found to be effective in 
ESBLs and non-ESBL producing uropathogens and can be 
considered as reserve drugs. However, Klebsiella spp. was 
most resistant to amoxicillin-clavulanic acid. Prevalence 
of ESBLs producers and presence of MDR indicates the 
rampant use of antibiotics, necessitating implementation of 
effective antibiotic policy.
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